Teladoc Stock News

Teladoc Health (TDOC) has added ~14% in the pre-market Monday after announcing a partnership with Amazon (AMZN) to launch its virtual healthcare service with the use of the tech…

Shares of Teladoc Health Inc. shot up 12.7% in premarket trading Monday, after the provider of tele-healthcare services said it has teamed up with Amazon.com Inc. Alexa on voice-activated virtual care services. The service will be available on Amazon Alexa devices, including the Echo, the Echo Dot and Echo Show. Amazon shares slipped 0.8% ahead of the open. Teladoc customers can say "Alexa, I want to talk to a doctor" to an Echo device and customers will then get a call back on their Echo devices. The service will cost as low as $0 with insurance or $75 without insurance. "Teladoc Health''s collaboration with Amazon is yet another step in breaking down barriers to healthcare access," said Teladoc Chief Product Officer Donna Boyer. "By introducing and integrating our virtual first care experience with Echo devices, we are providing an innovative and convenient way for users to connect with a doctor." Teladoc''s stock has tumbled 35.5% over the past three months through Friday, while the S&P 500 has lost 4.6%.

Shares of Teladoc Health Inc. undefined shot up 12.7% in premarket trading Monday, after the provider of tele-healthcare services said it has teamed up with…

Amazon Echo customers can access Teladoc’s telehealth services through their devices by asking Alexa to connect them with a doctor.

First of its Kind Alexa Experience Provides Hands-Free Access at Home to General Medical Care…

They show progress toward key goals.

The business is a lot safer than the stock''s movement suggests.

This risk has been a concern among investors.

Here''s the real scoop about the virtual care leader.

The telehealth provider reported robust financial results then got dragged lower by a falling market.

Shares of Teladoc Health, Inc. (NYSE: TDOC ) shares are lower after the telemedicine company issued below-consensus guidance for the first quarter. The Teladoc Analysts: Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc shares and reduced the price target from $170 to $100. Stifel analyst David Grossman maintained a Hold rating and lowered the price target from $83 to $74. KeyBanc Capital Markets analyst Donald Hooker reiterated an Overweight rating and took down the price target from $180 to $100. Teladoc''s Valuation Is Attractive, Needham Says: Teladoc finished fiscal year 2021 on a strong note, with revenue and adjusted EBITDA all exceeding the preannounced range, Needham analyst McDonald said. The delay in the launch of multiple chronic care customers has made revenues and margin expansion more weighted toward the second-half, the analyst said. Teladoc management shrugged it off, saying customers are already contracted and the outlook for the year remains … Full story available on Benzinga.

NEW YORK , Feb. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TJX, CERN, AAPL, TDOC, and ROKU. Full story available on Benzinga.com